{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Risk Factors for Serious Hypotension Following Intravenous Acetaminophen in Hematologic Malignancies: A Retrospective Case-Control Study"
      },
      "Trial_Design": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Participants": {
        "score": 2,
        "evidence": "Hospitalized patients with hematologic malignancies who received intravenous AAP were included."
      },
      "Intervention": {
        "score": 1,
        "evidence": "Hospitalized patients with hematologic malignancies who received intravenous AAP were included."
      },
      "Objective": {
        "score": 1,
        "evidence": "This study aimed to identify risk factors associated with this adverse event."
      },
      "Method_Outcome": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Randomisation_Allocation": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Blinding": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Randomised": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Number_Analysed": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Result_Outcome": {
        "score": 3,
        "evidence": "Elevated body temperature prior to administration (OR 9.81, 95% CI 3.49\u201327.53), acute kidney injury (OR 14.99, 95% CI 3.13\u201371.87), and bacteremia (OR 6.36, 95% CI 2.01\u201320.11) were identified as significant risk factors for serious hypotension."
      },
      "Harms": {
        "score": 1,
        "evidence": "This study aimed to identify risk factors associated with this adverse event."
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 8,
    "max_score": 25
  },
  "model": "gpt-4o"
}